Daslemia 50mg Tablet

Details

Daslemia 50mg Tablet contains Dasatinib, a targeted anti-cancer medicine belonging to the tyrosine kinase inhibitor group. It is used under specialist medical supervision for certain types of blood and bone marrow cancers.

Dasatinib works by blocking abnormal tyrosine kinase proteins that can promote the growth and multiplication of cancer cells. By interfering with these signals, the medicine helps slow or stop the growth of certain abnormal blood cells.

Daslemia is prescribed for specific forms of leukemia, including Philadelphia chromosome-positive chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia. Treatment should always be supervised by an experienced oncologist or hematologist.

Explore our Oncology & Cancer Care Collection for more specialized healthcare products.

What Is Daslemia 50mg Tablet?

Daslemia 50mg Tablet is an oral prescription medicine containing Dasatinib. It belongs to a group of medicines known as tyrosine kinase inhibitors, which target abnormal proteins involved in the growth and survival of certain cancer cells.

Dasatinib is particularly used in Philadelphia chromosome-positive leukemia. The Philadelphia chromosome is associated with an abnormal BCR-ABL protein that can promote uncontrolled growth of certain blood cells.

Daslemia blocks signals produced by abnormal tyrosine kinases and helps control the multiplication of cancer cells.

Daslemia should only be used according to the prescription and treatment plan provided by a qualified oncology specialist.

Daslemia 50mg Tablet Uses

Chronic Myeloid Leukemia

Dasatinib is used for certain Philadelphia chromosome-positive forms of chronic myeloid leukemia, including situations where previous treatment has not worked adequately or cannot be tolerated.

Philadelphia Chromosome-Positive Leukemia

Dasatinib targets abnormal BCR-ABL tyrosine kinase activity associated with Philadelphia chromosome-positive leukemia.

Acute Lymphoblastic Leukemia

Dasatinib may be used in selected patients with Philadelphia chromosome-positive acute lymphoblastic leukemia as determined by a specialist.

Benefits of Daslemia 50mg Tablet

Targeted Cancer Treatment

Dasatinib is a targeted therapy designed to act on specific abnormal tyrosine kinase proteins involved in the growth of certain cancer cells.

Helps Control Abnormal Cell Growth

By blocking specific signaling proteins, Dasatinib can help slow the multiplication and spread of susceptible abnormal blood cells.

Used in Specific Leukemia Types

Daslemia is used in carefully selected patients with Philadelphia chromosome-positive leukemia according to the diagnosis and treatment plan established by a specialist.

Oral Treatment Option

Daslemia is administered orally, allowing patients to take their prescribed treatment according to the schedule provided by their healthcare team.

Daslemia 50mg Tablet Composition

Daslemia 50mg Tablet contains:

• Dasatinib 50mg

Dasatinib is the active pharmaceutical ingredient responsible for the medicine's targeted tyrosine kinase inhibitory activity.

How Daslemia 50mg Tablet Works

Daslemia contains Dasatinib, which belongs to the tyrosine kinase inhibitor class of anti-cancer medicines.

Certain leukemia cells contain abnormal tyrosine kinase proteins, including BCR-ABL, that send signals promoting abnormal cell growth and survival. Dasatinib inhibits these abnormal signaling pathways.

By blocking these proteins, Dasatinib helps reduce the signals responsible for uncontrolled multiplication of susceptible cancer cells. This targeted mechanism helps control the disease under appropriate medical supervision.

How To Take Daslemia 50mg Tablet

Take Daslemia exactly as prescribed by your oncologist or other qualified healthcare professional.

Swallow the tablet whole with water. Do not crush, chew or break the tablet unless your doctor specifically instructs you otherwise.

Daslemia can generally be taken with or without food. Try to take it at approximately the same time each day to maintain a consistent treatment routine.

Do not change the dose, stop treatment or alter the treatment schedule without consulting your cancer specialist.

Daslemia 50mg Tablet Dosage

The appropriate Dasatinib dose depends on the type of leukemia, age, treatment history, response to therapy, other medicines and overall health.

The strength of this product is 50mg, but the appropriate number of tablets and frequency of administration must be determined by the treating specialist.

Do not use the 50mg strength as a general dosing recommendation. Take only the dose prescribed specifically for you.

Important Safety Information

• Daslemia is a prescription anti-cancer medicine and should be used only under specialist supervision.
• Take it exactly according to your oncologist's instructions.
• Do not crush, chew or break the tablet.
• Do not stop treatment without speaking with your doctor.
• Regular blood tests may be required during treatment.
• Tell your doctor if you have heart, liver or lung problems.
• Inform your doctor if you have experienced bleeding problems.
• Tell your doctor about every medicine, vitamin and supplement you take.
• Inform your doctor immediately about unusual bleeding or bruising.
• Seek medical advice if you develop fever or signs of infection.
• Tell your doctor if you are pregnant, planning pregnancy or breastfeeding.
• Keep the medicine out of reach of children.

Possible Side Effects

Daslemia can cause side effects because it affects cancer-related signaling pathways as well as some normal body processes. Possible side effects include nausea, vomiting, diarrhea, headache, tiredness, muscle or joint pain and skin rash.

Changes in blood cell counts can also occur. Low platelet counts, low white blood cell counts and other changes in blood counts may require monitoring during treatment.

More serious reactions can include fluid retention, swelling, bleeding, gastrointestinal bleeding, heart problems, pulmonary complications and other significant effects. Contact your treating healthcare professional promptly if you develop concerning symptoms.

Daslemia and Blood Cell Counts

Dasatinib treatment can affect blood cell counts. Your healthcare team may therefore order regular blood tests to monitor platelets, white blood cells, red blood cells and other important parameters.

Do not skip scheduled laboratory tests during treatment. Your doctor may temporarily adjust or interrupt treatment if significant blood-count abnormalities occur.

Daslemia and Fluid Retention

Dasatinib may cause fluid retention in some patients. Swelling, rapid weight gain, shortness of breath or other symptoms should be reported to your healthcare team.

Seek urgent medical attention if you develop significant breathing difficulty, chest discomfort or severe swelling.

Daslemia and Bleeding Risk

Dasatinib may increase the risk of bleeding, particularly when blood platelet levels are reduced or when it is used with certain medicines that affect blood clotting.

Inform your doctor about unusual bruising, prolonged bleeding, blood in the stool, black stools, vomiting blood or other signs of abnormal bleeding.

Daslemia During Pregnancy

Dasatinib can cause serious harm to an unborn baby. If you are pregnant, planning pregnancy or think you may be pregnant, inform your doctor immediately.

Effective contraception may be recommended during treatment according to your doctor's advice. Do not use Daslemia during pregnancy unless specifically directed by your specialist after careful consideration.

Daslemia During Breastfeeding

Breastfeeding is generally not recommended during Dasatinib treatment because the medicine may pose a risk to the infant.

Discuss breastfeeding and alternative feeding options with your oncologist before starting treatment.

Drug Interactions

Dasatinib can interact with a number of prescription medicines, over-the-counter medicines and supplements. Some interactions can significantly increase or decrease Dasatinib levels or increase the risk of adverse effects.

Tell your doctor about all medicines you currently use before starting Daslemia. This includes medicines for heart conditions, infections, stomach problems, blood clotting and other chronic conditions.

Do not start a new medicine, supplement or herbal product without checking with your healthcare professional.

Missed Dose

If you miss a dose of Daslemia, follow the missed-dose instructions provided by your oncologist or pharmacist. Do not take an extra dose unless your healthcare professional specifically instructs you to do so.

If you are unsure what to do after missing a dose, contact your treating healthcare team for specific advice.

Important Usage Tips

• Take Daslemia exactly as prescribed.
• Try to take it at the same time every day.
• Swallow the tablet whole with water.
• Do not crush or chew the tablet.
• Attend all scheduled blood tests and medical appointments.
• Tell your doctor about unusual bleeding or bruising.
• Report fever or signs of infection promptly.
• Report breathlessness, swelling or sudden weight gain.
• Tell your healthcare team about all medicines and supplements.
• Do not stop treatment without medical advice.
• Store the medicine according to the package instructions.

Frequently Asked Questions

What is Daslemia 50mg Tablet?

Daslemia 50mg Tablet is a prescription anti-cancer medicine containing Dasatinib 50mg. It belongs to the tyrosine kinase inhibitor class.

What is Daslemia 50mg Tablet used for?

Daslemia is used under specialist supervision for certain Philadelphia chromosome-positive blood cancers, including chronic myeloid leukemia and acute lymphoblastic leukemia.

What is the composition of Daslemia 50mg?

Daslemia 50mg Tablet contains Dasatinib 50mg as its active ingredient.

How does Daslemia work?

Dasatinib blocks abnormal tyrosine kinase proteins involved in the growth and survival of certain leukemia cells, helping slow abnormal cell multiplication.

Can Daslemia be taken while breastfeeding?

Breastfeeding is generally not recommended during Dasatinib treatment. Discuss this with your oncologist.

How should Daslemia be stored?

Store Daslemia according to the instructions provided on the product packaging. Current product information indicates storage below 30°C. Keep the medicine away from children. :contentReference[oaicite:3]{index=3}

Explore More Oncology Products

Explore our Oncology & Cancer Care Collection for more specialized healthcare products.

For general health information, visit MedlinePlus.

Disclaimer

This information is provided for general educational purposes and does not replace professional medical advice, diagnosis or treatment. Daslemia 50mg Tablet is a prescription anti-cancer medicine and should be used only under the supervision of a qualified healthcare professional.

Dosage, treatment duration, monitoring and treatment adjustments must be determined by the treating oncologist based on the patient's condition and response to therapy.

Specifications